Defining a new era of oligonucleotides

Defining a new era of oligonucleotides

Show all

Investor Inquiries

Press Releases

Press Releases

  • Sep 23, 2020
    Wave Life Sciences Prices $100 Million Public Offering of Ordinary Shares
    CAMBRIDGE, Mass. , Sept. 23, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today the pricing of its previously announced underwritten
  • Sep 22, 2020
    Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares
    CAMBRIDGE, Mass. , Sept. 22, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that it has commenced an underwritten public offering of